Neurologic manifestations of inflammatory bowel diseases

Handbook of Clinical Neurology

Volumn 120, Issue , 2014, Pages 595-605

  Ferro, José M ^a   Oliveira, Sofia N ^b   Correia, Luis ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DA LUZ   (Portugal)

Author keywords

Anti TNF ; Cerebral venous thrombosis; Crohn's disease; Inflammatory bowel disease; Polyneuropathy; Stroke; Ulcerative colitis; White matter lesions

Indexed keywords

ANTI-TNF-Α; ARTICLE; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHY SCANNER; CROHN DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYNEUROPATHY; ULCERATIVE COLITIS; WHITE MATTER LESIONS;

ANTI-TNF-Α; CEREBRAL VENOUS THROMBOSIS; CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; POLYNEUROPATHY; STROKE; ULCERATIVE COLITIS; WHITE MATTER LESIONS;

HUMANS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 84890844883     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4087-0.00040-1     Document Type: Chapter

References (121)

1. Akbayir N., Calis A.B., Alkim C., et al. Sensorineural hearing loss in patients with inflammatory bowel: a subclinical extraintestinal manifestation. Dig Dis Sci 2005, 50:1938-1945.
2. Aksamit A.J. Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2008, 10:178-185.
3. Askari A., Vignos P.J., Moskowitz R.W. Steroid myopathy in connective tissue disease. Am J Med 1976, 61:485-492.
4. Bachmeyer C., Leclerc-Landgraf N., Laurette F., et al. Acute autoimmune sensorineural hearing loss associated with Crohn's disease. Am J Gastroenterol 1998, 93:2565-2567.
5. Barclay A.R., Keightley J.M., Horrocks I., et al. Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2010, 16:677-683.
6. Baron B.W., Jeon H.R., Glunz C., et al. First two patients with ulcerative colitis who developed classic thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange. J Clin Apher 2002, 17:204-206.
7. Benavente L., Morís G. Neurologic disorders associated with inflammatory bowel disease. Eur J Neurol 2011, 18:138-143.
8. Bermejo P.E., Burgos A. Neurological complications of inflammatory bowel disease. Med Clin (Barc) 2008, 130:666-675.
9. Bernstein C.N., Blanchard J.F., Houston D.S., et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.
10. Bernstein C.N., Wajda A., Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005, 129:827-836.
11. Bhigjee A.I., Bill P.L., Cosnett J.E. Ulcerative colitis and interstitial myositis. Clin Neurol Neurosurg 1987, 89:261-263.
12. Biogen Idec Medical Information website. https://medinfo.biogenidec.com/medinfo/registration/reguser.do.
13. Bouma G., Oudkerk Pool M., Crusius J.B., et al. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin Exp Immunol 1997, 109:175-179.
14. Buccino G.P., Corrente G., Visintini D. Crohn's disease and multiple sclerosis: a single case report. Ital J Neurol Sci 1994, 15:303-306.
15. Bunim J.J., Ziff M., McEwen C. Evaluation of prolonged cortisone therapy in rheumatoid arthritis: a four-year study. Am J Med 1955, 18:27-40.
16. Carmona M.A., Jaume Anselmi F., Ramírez Rivera J. Cerebral thrombosis and vasculitis: an uncommon complication of ulcerative colitis. Bol Asoc Med P R 2000, 92:9-11.
17. Casella G., Spreafico C., Costantini M., et al. Cerebral sinus thrombosis in ulcerative colitis. Inflamm Bowel Dis 2011, 17:2214-2216.
18. Chebli J.M., Gaburri P.D., de Souza A.F., et al. Fatal evolution of systemic lupus erythematosus associated with Crohn's disease. Arq Gastroenterol 2000, 37:224-226.
19. Cognat E., Crassard I., Denier C., et al. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review. Int J Stroke 2011, 6:487-492.
20. Cohen M., Baldin B., Thomas P., et al. Neurological adverse events under anti-TNF alpha therapy. Rev Neurol (Paris) 2012, 168:33-39.
21. Cosnes J., Blain A., Cattan, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
22. Derbyshire S.W.G. A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol 2003, 98:12-20.
23. Derrey S., Charpentier C., Gérardin E., et al. Inflammatory pseudotumor of the cerebellum in a patient with Crohn's disease. World Neurosurg 2012, 77:201.e13-201.e16.
24. Eggspühler A.W., Bauerfeind P., Dorn T., et al. Wernicke encephalopathy - a severe neurological complication in a clinically inactive Crohn's disease. Eur Neurol 2003, 50:184-185.
25. Eguren C., Díaz Ley B., Daudén E., et al. Peripheral neuropathy in two patients with psoriasis in treatment with infliximab. Muscle Nerve 2009, 40:488-489.
26. Einhäupl K., Bousser M.G., de Bruijn S.F., et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006, 13:553-559.
27. Elsehety A., Bertorini T.E. Neurologic and neuropsychiatric complications of Crohn's disease. South Med J 1997, 90:606-610.
28. Finnie I.A., Shields R., Sutton R., et al. Crohn's disease and myasthenia gravis: a possible role for thymectomy. Gut 1994, 35:278-279.
29. Freeman H.J., Flak B. Demyelination-like syndrome in Crohn's disease after infliximab therapy. Can J Gastroenterol 2005, 19:313-316.
30. Frytak S., Moertel C.H., Childs D.S. Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med 1978, 88:361-362.
31. Fuller-Thomson E., Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006, 12:697-707.
32. Geissler A., Andus T., Roth M., et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995, 345:897-898.
33. Gelfenbeyn M., Goodkin R., Kliot M. Sterile recurrent spinal epidural abscess in a patient with Crohn's disease: a case report. Surg Neurol 2006, 65:178-184.
34. Gendelman S., Present D., Janowitz H.D. Neurological complications of inflammatory bowel disease. Gastroenterology 1982, 82:1065.
35. Gibb W.R.G., Dhillon D.P., Zilkha K.J., et al. Bronchiectasis with ulcerative colitis and myelopathy. Thorax 1987, 42:155-156.
36. Glotzer D.J., Yuan R.H., Patterson J.F. Ulcerative colitis complicated by toxic megacolon, polyserositis and hemorrhagic leukoencephalitis with recovery. Ann Surg 1964, 159:445-450.
37. Gobron C., Kaci R., Sokol H., et al. Unilateral carotid granulomatous arteritis and Crohn's disease. Rev Neurol (Paris) 2010, 166:542-546.
38. Gondim F.A., Brannagan T.H., Sander H.W., et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 2005, 128:867-879.
39. Gupta G., Gelfand J.M., Lewis J.D. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005, 129:819-826.
40. Ha C., Magowan S., Accortt N.A., et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009, 104:1445-1451.
41. Hahn J.S., Berquist W., Alcorn D.M., et al. Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage. Pediatrics 1998, 101:E10.
42. Halloran T.J. Convulsions associated with high cumulative doses of metronidazole. Drug Intell Clin Pharm 1982, 16:409.
43. Hayashi K., Kurisu Y., Ohshiba J., et al. Report of a case of Crohn's disease associated with hyper-creatine phosphokinasemia. Jpn J Med 1991, 30:441-445.
44. Heidemann J., Spinelli K.S., Otterson M.F., et al. Case report: magnetic resonance imaging in the diagnosis of epidural abscess perirectal fistulizing Crohn's disease. Inflamm Bowel Dis 2003, 9:122-124.
45. Hershkowitz S., Link R., Ravden M., et al. Spinal empyema in Crohn's disease. J Clin Gastroenterol 1990, 12:67-69.
46. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Eng J Med 1996, 334:494-500.
47. Hisada T., Miyamae Y., Mizuide M., et al. Acute thrombocytopenia associated with preexisting ulcerative colitis successfully treated with colectomy. Intern Med 2006, 45:87-91.
48. Holzer K., Esposito L., Stimmer H., et al. Cerebral vasculitis mimicking migraine with aura in a patient with Crohn's disease. Acta Neurol Belg 2009, 109:44-48.
49. Jacob A., Ledingham J.G., Kerr A.I., et al. Ulcerative colitis and giant cell arteritis associated with sensorineural deafness. J Laryngol Otol 1990, 104:889-890.
50. Johns D.R. Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol 1991, 86:367-370.
51. Kappelman M.D., Horvath-Puho E., Sandler R.S., et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011, 60:937-943.
52. Katsanos A.H., Katsanos K.H., Kosmidou M., et al. Cerebral sinus venous thrombosis in inflammatory bowel diseases. QJM 2013, 106:401-413.
53. Kawakubo K., Iida M., Matsumoto T., et al. Progressive encephalopathy in a Crohn's disease patient on long-term total parenteral nutrition: possible relationship to selenium deficiency. Postgrad Med J 1994, 70:215-219.
54. Kimura K., Hunter S.F., Thollander M.S., et al. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clin Proc 2000, 75:802-806.
55. Konturek S.J., Konturek J.W., Pawlik T., et al. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 2004, 55:137-154.
56. Kothur K., Kaul S., Rammurthi S., et al. Use of thrombolytic therapy in cerebral venous sinus thrombosis with ulcerative colitis. Ann Indian Acad Neurol 2012, 15:35-38.
57. Kraus J.A., Nahser H.C., Berlit P. Lymphocytic encephalomyeloneuritis as a neurologic complication of ulcerative colitis. J Neurol Sci 1996, 141:117-119.
58. Kreuzpaintner G., Horstkotte D., Heyll A., et al. Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med 1992, 92:391-395.
59. Kugathasan S., Collins N., Maresso K., et al. CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol 2004, 2:1003-1009.
60. Kumar B.N., Smith M.S.H., Walsh R.M., et al. Sensorineural hearing loss in ulcerative colitis. Clin Otolaryngol 2000, 25:143-145.
61. Kumar D., Bouldin T.W., Berger R.G. A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis Rheum 2010, 62:3191-3195.
62. Kusumi R.K., Plouffe J.F., Wyatt R.H., et al. Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 1980, 93:59-60.
63. Lahari D., Debeugny S., Peeters M., et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001, 120:816-819.
64. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 170(Suppl):2-6.
65. Lloyd D.A., Payton K.B., Guenther L., et al. Melkersson-Rosenthal syndrome and Crohn's disease: one disease or two? Report of a case and discussion of the literature. J Clin Gastroenterol 1994, 18:213-217.
66. Lossos A., River Y., Eliakim A., et al. Neurologic aspects of inflammatory bowel disease. Neurology 1995, 45:416-421.
67. Mandell D.M., Matouk C.C., Farb R.I., et al. Vessel wall MRI to differentiate between reversible cerebral vasoconstriction syndrome and central nervous system vasculitis: preliminary results. Stroke 2012, 43:860-862.
68. Martín de Carpi J., Ribó Cruz J.M., Antón López J., et al. Cerebral vasculitis associated with ulcerative colitis. An Pediatr (Barc) 2007, 67:177-178.
69. Martin R.W., Shah A. Myasthenia gravis coexistent with Crohn's disease. J Clin Gastroenterol 1991, 13:112-113.
70. Miehsler W., Reinisch W., Valic E., et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 2004, 53:542-548.
71. Milandre L., Monges D., Dor V., et al. Cerebral phlebitis and Crohn disease. Rev Neurol (Paris) 1992, 148:139-144.
72. Mohan N., Edwards E.T., Cupps T.R., et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001, 44:2862-2869.
73. Molodecky N.A., Soon I.S., Rabi D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
74. Nelson J., Barron M.M., Riggs J.E., et al. Cerebral vasculitis and ulcerative colitis. Neurology 1986, 36:719-721.
75. Newton P., Aldridge R.D., Lesseells A.M., et al. Progressive multifocal leukoencephalopathy complicating systemic lupus erythematous. Arthritis Rheum 1986, 29:337-343.
76. Novacek G., Weltermann A., Sobala A., et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010, 139:779-787.
77. Nudelman R.J., Rosen D.G., Rouah E., et al. Cerebral sinus thrombosis: a fatal neurological complication of ulcerative colitis. Pathol Res Int 2010, 2010:132754.
78. Ogawa E., Sakakibara R., Yoshimatsu Y., et al. Crohn's disease and stroke in a young adult. Intern Med 2011, 50:2407-2408.
79. Oliveira G.R., Teles B.C., Brasil E.F., et al. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis 2008, 14:389-395.
80. Orholm M., Binder V., Sørensen T.I., et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000, 35:1075-1081.
81. Pandian J.D., Pawar G., Singh G.S., et al. Multiple sclerosis in a patient with chronic ulcerative colitis. Neurol India 2004, 52:282-283.
82. Papa A., Danese S., Grillo A., et al. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003, 98:1247-1251.
83. Papi C., Ciaco A., Acierno G., et al. Severe ulcerative colitis, dural sinus thrombosis, and the lupus anticoagulant. Am J Gastroenterol 1995, 90:1514-1517.
84. Perkin G.D., Murray-Lyon I. Neurology and the gastrointestinal system. J Neurol Neurosurg Psychiatry 1998, 65:291-300.
85. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., et al. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflamm Bowel Dis 2011, 17:471-478.
86. Philips M.F., Bagley L.J., Sinson G.P., et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999, 90:65-71.
87. Porter C.K., Tribble D.R., Aliaga P.A., et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008, 135:781-786.
88. Purrmann J., Arendt G., Cleveland S., et al. Association of Crohn's disease and multiple sclerosis. Is there a common background?. J Clin Gastroenterol 1992, 14:43-46.
89. Rang E.H., Brooke B.N., Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis. Lancet 1982, 2:555.
90. Ray D.W., Bridger J., Hawnaur J., et al. Transverse myelitis as the presentation of Jo-1 antibody syndrome (myositis and fibrosing alveolitis) in long-standing ulcerative colitis. Br J Rheumatol 1993, 32:1105-1108.
91. Ronchetto F., Pistono P.G. Temporal arteritis in a patient with ulcerative colitis. Coincidental association or (immuno) pathogenetic link?. Recenti Prog Med 1993, 84:54-56.
92. Sacher M., Göpfrich H., Hochberger O. Crohn's disease penetrating into the spinal canal. Acta Paediatr Scand 1989, 78:647-649.
93. Sadovnick A.D., Paty D.W., Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease. N Eng J Med 1989, 321:762-763.
94. Sandborn W.J., Colombel J.F., Enns R., et al. Natalizumab induction and maintenance therapy for Crohn's disease. N Eng J Med 2005, 353:1912-1925.
95. Santos S., Casadevall T., Pascual L.F., et al. Neurological alterations related to Crohn's disease. Rev Neurol 2001, 32:1158-1162.
96. Saposnik G., Barinagarrementeria F., Brown R.D., et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:1158-1192.
97. Sassi S.B., Kallel L., Ben Romdhane S., et al. Peripheral neuropathy in inflammatory bowel disease patients: a prospective cohort study. Scand J Gastroenterol 2009, 44:1268-1269.
98. Satsangi J., Jewell D.P., Bell J.L. The genetics of inflammatory bowel disease. Gut 1997, 40:572.
99. Scheid R., Teich N. Neurologic manifestations of ulcerative colitis. Eur J Neurol 2007, 14:483-493.
100. Schluter A., Krasnianski M., Krivokuca M., et al. Magnetic resonance angiography in a patient with Crohn's disease associated cerebral vasculitis. Clin Neurol Neurosurg 2004, 106:110-113.
101. Schneidermann J.H., Sharpe J.A., Sutton D.M. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol 1979, 5:331-337.
102. Schoonjans R., Mast A., Van Den Abeele G., et al. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease. Am J Gastroenterol 1993, 88:1416-1420.
103. Schwartz R.B., Bravo S.M., Klufas R.A., et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995, 165:627-631.
104. Schwartz D.A., Loftus E.V., Tremaine W.J., et al. The natural history of fistulizing Crohn's disease in Olmested County, Minnesota. Gastroenterology 2002, 122:875-880.
105. Sedwick L.A., Klingele T.G., Burde R.M., et al. Optic neuritis in inflammatory bowel disease. J Clin Neuroophthalmol 1984, 4:3-6.
106. Sheffield W.D., Squire R.A., Strandberg J.D. Cerebral venous thrombosis in the rhesus monkey. Vet Pathol 1981, 18:326-334.
107. Shimoyama T., Tamura Y., Sakamoto T., et al. Immune-mediated myositis in Crohn's disease. Muscle Nerve 2009, 39:101-105.
108. Shin I.S., Baer A.N., Kwon H.J., et al. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 2006, 54:1429-1434.
109. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular, and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastrenterology. Can J Gastroenterol 2005, 19(Suppl A):5-36.
110. Simsek I., Erdem H., Pay S., et al. Optic neuritis occurring with anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 2007, 66:1255-1258.
111. Sowa J.M. Overlapping polymyositis and ulcerative colitis: HTLV-1 infection as an alternative explanation. J Rheumatol 1991, 18:1939.
112. Suzuki I., Watanabe N., Suzuki J., et al. A case of bronchiectasis accompanied by ulcerative colitis and HTLV-1 associated myelopathy (HAM). Jpn J Thorac Dis 1994, 32:358-363.
113. Talbot R.W., Heppell J., Dozois R.R., et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986, 61:140-145.
114. Thomas C.W., Weinshenker B.G., Sandborn W.J. Demyelination during anti-tumor necrosis factor therapy with infliximab for Crohn's disease. Inflamm Bowel Dis 2004, 10:28-31.
115. Tsujikawa T., Urabe M., Bamba H., et al. Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: a case report of successful treatment by anticoagulant therapy. J Gastroenterol Hepatol 2000, 15:688-692.
116. Ullrich S., Schinke S., Both M., et al. Refractory central nervous system vasculitis and gastrocnemius myalgia syndrome in Crohn's disease successfully treated with anti-tumor necrosis factor-alpha antibody. Semin Arthritis Rheum 2009, 38:337-347.
117. Van Assche G., Van Ranst M., Sciot R., et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Eng J Med 2005, 353:362-368.
118. Vannucchi V., Grazzini M., Pieralli F., et al. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease. J Gastrointestin Liver Dis 2011, 20:201-203.
119. Vavricka S.R., Brun L., Ballabini P., et al. Frequency and risk factors of extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011, 106:110-119.
120. Wijdicks E.F., Wiesner R.H., Krom R.A. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 1995, 45:1962-1964.
121. Zois C.D., Katsanos K., Kosmidou M., et al. Neurological manifestation of inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis 2010, 4:115-124.